论文部分内容阅读
应用米索前列醇栓及催产素对９０例单胎头位初、经产妇进行足月妊娠引产效果的对照观察，随机分为两组，米索栓组６０例，催产素组３０例。结果：米索栓组及催产素组引产总有效率分别为１００％与６０％，Ｐ＜０．００１，差异极为显著；两组剖宫产率分别为６．６％与４０％，Ｐ＜０．００１，差异极为显著；两组新生儿窒息率分别３．３％与２０％，Ｐ＜０．００１，差异极为显著；两组产后２小时出血量分别为１７４＋３３ｍｌ与２０２＋３７ｍｌ，Ｐ＜０．０２，有显著性差异。结论：新型引产药物米索前列醇栓用于足月妊娠引产疗效显著、安全、方便，值得临床推广
Application of misoprostol suppository and oxytocin on 90 cases of single head position, the mothers of full-term pregnancy induced labor control effect of the observation were randomly divided into two groups, misoprostol group 60 cases, oxytocin group 30 cases. Results: The total effective rates of misoprostol and oxytocin were 100% and 60% respectively, P <0.001, the difference was significant. The cesarean section rates of the two groups were 6.6% and 40%, P < 0.001, the difference was extremely significant. Asphyxia rate of newborns in both groups was 3.3% and 20% respectively, P <0.001, the difference was extremely significant. The amount of bleeding in two groups after delivery was 174 + 33ml and 202 + 37ml respectively, P <0. 02, there are significant differences. Conclusion: The new misoprostol misoprostol suppository for full-term pregnancy induction of labor is significant, safe and convenient, worthy of clinical promotion